- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Piramal Pharma Limited — Updates, 29-07-2026: Press Release
29-07-2026 | 08:49 pm
29-07-2026 | 08:49 pm
Piramal Pharma reported Q1 FY27 revenue up 17% to ₹2,270 Cr, and EBITDA surged 72% to ₹285 Cr (12.5% margin). Growth across all segments with improved execution. CDMO strong, CHG gained ex-US traction, PCH boosted by Power Brands.
No comments yet. Be the first to comment!